Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.
Mosaic Therapeutics appoints Dr Barry Davies as CSO
- Post author:
- Post published:October 8, 2024
- Post category:uncategorized